Nano‐G s Protein Peptidomimetics: Rational Design of Gα C‐Terminus‐Derived Peptides Mimicking Key Components of G s ‐β 2 AR Interactions
Authors:
- Phuong Thu TranPTPhuong Thu Tran
- Mia DanielsenMDMia Danielsen
- Johanna K. S. TiemannJTJohanna K. S. Tiemann
- Passainte IbrahimPIPassainte Ibrahim
- Søren G. F. RasmussenSRSøren G. F. Rasmussen
- Xavier KubiakXKXavier Kubiak
- Hossein BatebiHBHossein Batebi
- Charlène GadaisCGCharlène Gadais
- Steven BalletSteven Ballet
- Peter W. HildebrandPHPeter W. Hildebrand
- Daniel Sejer PedersenDPDaniel Sejer Pedersen
- Jesper Mosolff MathiesenJMJesper Mosolff Mathiesen
Open Access
- 23 April 2026
- journal article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (24) , e23510
Abstract
G protein‐coupled receptors (GPCRs) are involved in most human physiological processes and one of the largest families of approved drug‐targeted proteins. Heterotrimeric Gαβɣ proteins bind to the intracellular cavity of the activated receptor mainly through the C‐terminal α5 helix of the Gα subunit (GαCT). Modulation of GPCR activity through intracellular GPCR binding sites is emerging. Here we develop highly active Gα s CT‐derived peptidomimetics that stabilize the β 2 adrenergic receptor (β 2 AR) in an active‐like conformation when the helical conformation of Gα s CT is preserved by a covalent tether (“staple”). By rational design, integrating the information of two crystal structures showing different binding modes of Gα s CT with β 2 AR, an appropriate staple position was identified. The key interactions observed in the two distinct β 2 AR structures (β 2 AR‐G s (empty)) and β 2 AR‐T4L‐G s CT‐CC), namely Y391 and E392, were substituted with non‐canonical amino acids to improve activity. Optimization resulted in the identification of a potent peptidomimetic capable of stabilizing an active‐like receptor conformation, whilst blocking receptor‐mediated cAMP formation. Molecular dynamics simulations indicated a peptidomimetic binding mode that may represent another intermediate state preceding that of β 2 AR‐G s (empty). We envision this approach to be useful for further structural and functional exploration of other GPCRs or as a tool in drug discovery.Keywords
Funding Information
- Lundbeck Foundation (R171‐2014‐361)
- Lundbeck Foundation (R37‐A3457)
- Stiftung Charité
This publication has 72 references indexed in Scilit:
- Development of Generic G Protein Peptidomimetics Able to Stabilize Active State Gs Protein‐Coupled Receptors for Application in Drug DiscoveryAngewandte Chemie International Edition, 2021
- Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptorBiochimica et Biophysica Acta (BBA) - General Subjects, 2019
- Rational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β2 Adrenergic Receptor LigandsChemistry – A European Journal, 2017
- Diversity‐Oriented Peptide Stapling: A Third Generation Copper‐Catalysed Azide–Alkyne Cycloaddition Stapling and Functionalisation StrategyChemistry – A European Journal, 2017
- CHARMM-GUIMembrane Buildertoward realistic biological membrane simulationsJournal of Computational Chemistry, 2014
- Extension of the CHARMM general force field to sulfonyl‐containing compounds and its utility in biomolecular simulationsJournal of Computational Chemistry, 2012
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009
- CHARMM: The biomolecular simulation programJournal of Computational Chemistry, 2009
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- Comparative Protein Structure Modeling Using ModellerCurrent Protocols in Bioinformatics, 2006